文章名稱引用次數(shù)

• The use of viscoelastic haemostatic assays in the management of major bleeding A British Society for Haematology Guideline40
• Cobomarsen, an oligonucleotide inhibitor of miR- co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma39
• Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy35
• Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis31
• A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma30
• Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways25
• Advances in understanding the pathogenesis of acquired aplastic anaemia23
• The full spectrum of Castleman disease: 273 patients studied over 20 years22
• Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis21
• How I manage patients with relapsed/refractory diffuse large B cell lymphoma21